CLVR — Clever Leaves Holdings Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.02m
- -$5.59m
- $17.42m
Brief: Clever Leaves Holdings' Unit Northern Swan Deutschland Entered Into First Share Purchase And Transfer Agreement
Brief: Clever Leaves Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Clever Leaves Says Colombian Flower Is Now Available To Australian Patients
Brief: Clever Leaves And Astrasana Partner To Establish International Supply Agreement For Medical Cannabis Extracts In Czech Republic And Switzerland
Brief: Clever Leaves Partners With SOMAÍ Pharmaceuticals And Sends First Commercial Shipments To Portugal
Brief: Clever Leaves Granted Brazilian GMP Certification For Cannabis Products By ANVISA
Brief: Clever Leaves Reports First Quarter 2023 Results
Clever Leaves Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Clever Leaves Expands Presence In Brazil Through Partnership With Hypera Pharma
Brief: Clever Leaves And Praetorian Agrees To Produce Cannabis Genetics In Colombia
Clever Leaves Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Clever Leaves Reports Fourth Quarter And Full Year 2022 Results
Clever Leaves Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Clever Leaves Holdings Inc - Expects To Complete Restructuring Actions In First Half Of Fiscal 2023
Brief: Clever Leaves Announces Wind-Down Of Portugal Operations As Part Of Ongoing Restructuring Initiatives
Clever Leaves Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Clever Leaves Reports Third Quarter 2022 Results
Clever Leaves Holdings Inc expected to post a loss of 17 cents a share - Earnings Preview
Clever Leaves Holdings Inc reports results for the quarter ended in June - Earnings Summary